These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 8633095)

  • 1. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.
    Arya SK; Gallo RC
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4486-91. PubMed ID: 8633095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of simian immunodeficiency virus from African green monkeys and human immunodeficiency virus type 2.
    Shibata R; Adachi A; Sakai H; Ishimoto A; Miura T; Hayami M
    J Med Primatol; 1990; 19(3-4):217-25. PubMed ID: 2231682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of a biologically contained replication system for human immunodeficiency virus type 1.
    Chen H; Boyle TJ; Malim MH; Cullen BR; Lyerly HK
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7678-82. PubMed ID: 1502183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AIDS virus. What we know and what we can do about it.
    Wong-Staal F
    West J Med; 1991 Nov; 155(5):481-7. PubMed ID: 1687714
    [No Abstract]   [Full Text] [Related]  

  • 7. Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element.
    Garzino-Demo A; Gallo RC; Arya SK
    Hum Gene Ther; 1995 Feb; 6(2):177-84. PubMed ID: 7734518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.
    Malim MH; Böhnlein S; Fenrick R; Le SY; Maizel JV; Cullen BR
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8222-6. PubMed ID: 2682638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene.
    Harrison GS; Long CJ; Curiel TJ; Maxwell F; Maxwell IH
    Hum Gene Ther; 1992 Oct; 3(5):461-9. PubMed ID: 1329991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.
    Chang HK; Gendelman R; Lisziewicz J; Gallo RC; Ensoli B
    Gene Ther; 1994 May; 1(3):208-16. PubMed ID: 7584083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication.
    Ahmad N; Maitra RK; Venkatesan S
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6111-5. PubMed ID: 2788283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
    Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
    Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
    Shuh M; Hill SA; Derse D
    Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective HIV-1 quasispecies in the form of multiply drug-resistant proviral DNA within cells can be rescued by superinfection with different subtype variants of HIV-1 and by HIV-2 and SIV.
    Quan Y; Xu H; Wainberg MA
    J Antimicrob Chemother; 2014 Jan; 69(1):21-7. PubMed ID: 23963235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.
    Liu J; Woffendin C; Yang ZY; Nabel GJ
    Gene Ther; 1994 Jan; 1(1):32-7. PubMed ID: 7584057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes.
    Bahner I; Zhou C; Yu XJ; Hao QL; Guatelli JC; Kohn DB
    J Virol; 1993 Jun; 67(6):3199-207. PubMed ID: 8388497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.
    McCormick-Davis C; Dalton SB; Hout DR; Singh DK; Berman NE; Yong C; Pinson DM; Foresman L; Stephens EB
    Virology; 2000 Jun; 272(1):112-26. PubMed ID: 10873754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of a noncytopathic human immunodeficiency virus type 1 (HIV-1) with target cells: efficient virus entry followed by delayed expression of its RNA and protein.
    Ma XY; Sakai K; Sinangil F; Golub E; Volsky DJ
    Virology; 1990 May; 176(1):184-94. PubMed ID: 2184575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionality of chimeric Rev proteins of HIV/SIV.
    Furuta RA; Sakai H; Kawamura M; Tokunaga K; Hatanaka M; Adachi A
    Virus Genes; 1995; 11(1):11-14. PubMed ID: 8808329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.